Fortive (NYSE: FTV) — Company Overview, News & Financial Data
Fortive delivers industrial technologies and digital solutions globally, focusing on efficiency and safety in critical industries.
Fortive
Fortive is a diversified industrial technology conglomerate headquartered in Everett, Washington. The company designs, develops, and manufactures essential technologies, software, and hardware solutions across two primary business segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Its product portfolio includes test and measurement instruments, environmental monitoring systems, enterprise asset management software, infection prevention devices, radiation dosimetry tools, and surgical workflow automation applications. Operating globally, the company serves customers across diverse sectors including industrial manufacturing, healthcare, utilities, corporate real estate, and public infrastructure, providing equipment and digital tools that support operational safety, facility efficiency, and clinical care standards.
Snapshot
Operations
Products and/or services of Fortive
- Safety and Hazard Detection: Provision of critical gas detection systems, portable test equipment, and environmental safety devices designed to identify workplace hazards, maintain electrical infrastructure, and ensure regulatory compliance across industrial facilities and utility networks worldwide.
- Predictive Maintenance and Enterprise Asset Management: Supply of cloud-based asset management software, computerized maintenance management tools, and industrial IoT sensors that monitor equipment performance, optimize facility operations, prevent costly system failures, and track real-time operational workflows globally.
- Facility and Construction Management Platforms: Development of capital planning software, facility cost estimation databases, and contractor management applications designed to streamline facility lifecycles, manage procurement, and improve operational productivity across corporate real estate and infrastructure sectors.
- Infection Prevention and Sterilization Systems: Manufacturing of low-temperature terminal sterilization hardware, high-level chemical disinfection consumables, and automated endoscope reprocessors utilized by acute care hospitals and surgical centers to eliminate pathogens and maintain sterile processing standards.
- Radiation Protection and Medical Quality Assurance: Production of radiation measurement devices, personal radiation monitoring dosimeters, and specialized biomedical test equipment that ensure regulatory compliance, calibrate medical imaging systems, and safeguard healthcare personnel in hospital radiology departments.
- Clinical Documentation and Surgical Workflow Software: Provision of specialized clinical workflow platforms, gastroenterology procedure documentation systems, and automated surgical charting tools designed to reduce administrative burdens, increase clinical efficiency, and improve patient care standards across medical facilities.
Fortive executive team
- Olumide O. SoroyePresident, CEO & Director
- Mark D. OkerstromSenior VP & CFO
- Peter C. UnderwoodSenior VP & Chief Legal Officer
- Christopher M. MulhallChief Accounting Officer
- Victor P. Fetter IIISenior VP & Chief Technology and Business System Officer
- Christina JonesVice President of Investor Relations
- Amee DesjourdySenior VP & Chief People Officer
- Parker BurkePresident of Fluke & Group President of Connected Reliability Group (CRG)
- Arul ElumalaiPresident of Gordian and Group President of Facilities & Asset Lifecycle (FAL) Group
- Chad RohrerPresident of ASP & Group President of Infection Prevention Group (IPG)
Dividend history
Dividends per share paid by Fortive , by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $0.1900 |
| FY2025 | — | — | — | $0.2906 |
| FY2024 | — | — | — | $0.2412 |
| FY2023 | — | — | — | $0.2185 |
| FY2022 | — | — | — | $0.2110 |
Key financials
Reported results for Fortive , in USD.
- Market cap
- 19.9B
- Revenue (TTM)
- 4.4B
- P/E ratio
- 31.7
- EPS (diluted, TTM)
- 2.1
- Dividend yield
- 0.4%
- Profit margin
- 14.8%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 5.1B | 908.9M | 579.2M | |
| 6.2B | 1.2B | 832.9M | |
| 6.1B | 1.1B | 865.8M | |
| 5.8B | 1B | 755.2M |